EUVIMEDEUVIMED entdecken
Kommentar

A common [18F]-FDG PET radiomic signature to predict survival in patients with HPV-induced cancers

Stephane Niyoteka iD, Romain-David Seban, Rahimeh Rouhi, Andrew Scarsbrook, Catherine Genestie, Marion Classe, Alexandre Carré, Roger Sun, Agustina La Greca Saint-Esteven, Cyrus Chargari, Jack McKenna, Garry McDermott und 7 weitere

European Journal of Nuclear Medicine and Molecular Imaging · 2023

DOI: 10.1007/s00259-023-06320-2 ↗

Kurz gefasst

Kommentar in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, 2023. Verfasst von Stephane Niyoteka und 18 weiteren Autor:innen. Beteiligte Einrichtung: Université Paris Saclay, INSERM UMR1030, Gustave Roussy, 94805, Villejuif, France. stephane.niyoteka@gustaveroussy.fr. Hauptthemen laut MEDLINE: Papillomavirus Infections, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms, Anus Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 71 Literaturangaben. Gefördert von: Cancer Research UK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Locally advanced cervical cancer (LACC) and anal and oropharyngeal squamous cell carcinoma (ASCC and OPSCC) are mostly caused by oncogenic human papillomaviruses (HPV). In this paper, we developed machine learning (ML) models based on clinical, biological, and radiomic features extracted from pre-treatment fluorine-18-fluorodeoxyglucose positron emission tomography ([18F]-FDG PET) images to predict the survival of patients with HPV-induced cancers. For this purpose, cohorts from five institutions were used: two cohorts of patients treated for LACC including 104 patients from Gustave Roussy Campus Cancer (Center 1) and 90 patients from Leeds Teaching Hospitals NHS Trust (Center 2), two datasets of patients treated for ASCC composed of 66 patients from Institut du Cancer de Montpellier (Center 3) and 67 patients from Oslo University Hospital (Center 4), and one dataset of 45 OPSCC patients from the University Hospital of Zurich (Center 5). Radiomic features were extracted from baseline [18F]-FDG PET images. The ComBat technique was applied to mitigate intra-scanner variability. A modified consensus nested cross-validation for feature selection and hyperparameter tuning was applied on four ML models to predict progression-free survival (PFS) and overall survival (OS) using harmonized imaging features and/or clinical and biological variables as inputs. Each model was trained and optimized on Center 1 and Center 3 cohorts and tested on Center 2, Center 4, and Center 5 cohorts. The radiomic-based CoxNet model achieved C-index values of 0.75 and 0.78 for PFS and 0.76, 0.74, and 0.75 for OS on the test sets. Radiomic feature-based models had superior performance compared to the bioclinical ones, and combining radiomic and bioclinical variables did not improve the performances. Metabolic tumor volume (MTV)-based models obtained lower C-index values for a majority of the tested configurations but quite equivalent performance in terms of time-dependent AUCs (td-AUC). The results demonstrate the possibility of identifying common PET-based image signatures for predicting the response of patients with induced HPV pathology, validated on multi-center multiconstructor data.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Papillomavirus InfectionsCarcinoma, Squamous CellUterine Cervical NeoplasmsAnus NeoplasmsFemaleHumansFluorodeoxyglucose F18Human Papillomavirus VirusesRetrospective StudiesPositron-Emission TomographyPositron Emission Tomography Computed TomographyFluorine Radioisotopes

Stichwörter der Autor:innen

ASCCComBatHumano papillomavirusLACCOPSCCRadiomics[18F]-FDG PET

Substanzen

Fluorodeoxyglucose F18Fluorine-18Fluorine Radioisotopes

Autor:innen und Institutionen

  • Université Paris Saclay, INSERM UMR1030, Gustave Roussy, 94805, Villejuif, France. stephane.niyoteka@gustaveroussy.fr.
  • Department of Radiation Oncology, Gustave Roussy, F-94805, Villejuif, France. stephane.niyoteka@gustaveroussy.fr.
  • Department of Nuclear Medicine, Institut Curie, Saint Cloud, France.
  • Department of Nuclear Medicine, Gustave Roussy, 94805, Villejuif, France.
  • Université Paris Saclay, INSERM UMR1030, Gustave Roussy, 94805, Villejuif, France.
  • Department of Radiation Oncology, Gustave Roussy, F-94805, Villejuif, France.

ORCID-Profile: Stephane Niyoteka

Förderung

  • Cancer Research UK

Zitieren

APA

Niyoteka, S., Seban, R. D., Rouhi, R., Scarsbrook, A., Genestie, C., Classe, M., Carré, A., Sun, R., La Greca Saint-Esteven, A., Chargari, C., McKenna, J., McDermott, G., Malinen, E., Tanadini-Lang, S., Guckenberger, M., Guren, M. G., Lemanski, C., Deutsch, E., & Robert, C. (2023). A common [18F]-FDG PET radiomic signature to predict survival in patients with HPV-induced cancers. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-023-06320-2

Vancouver

Niyoteka S, Seban RD, Rouhi R, Scarsbrook A, Genestie C, Classe M, et al. A common [18F]-FDG PET radiomic signature to predict survival in patients with HPV-induced cancers. European Journal of Nuclear Medicine and Molecular Imaging. 2023. doi:10.1007/s00259-023-06320-2

BibTeX
@article{Niyoteka2023,
  author = {Niyoteka, Stephane and Seban, Romain-David and Rouhi, Rahimeh and Scarsbrook, Andrew and Genestie, Catherine and Classe, Marion and Carré, Alexandre and Sun, Roger and La Greca Saint-Esteven, Agustina and Chargari, Cyrus and McKenna, Jack and McDermott, Garry and Malinen, Eirik and Tanadini-Lang, Stephanie and Guckenberger, Matthias and Guren, Marianne G and Lemanski, Claire and Deutsch, Eric and Robert, Charlotte},
  title = {A common [18F]-FDG PET radiomic signature to predict survival in patients with HPV-induced cancers},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2023},
  doi = {10.1007/s00259-023-06320-2}
}
Kostenlos starten →